Biodesix Inc. (BDSX) Misses Q3 EPS by 110c

Biodesix Inc. (NASDAQ: BDSX) reported Q3 EPS of ($1.16), $1.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $20.83 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS